Mardil Medical is receiving $6.125 million from Agensi Inovasi Malaysia, according to the Minnesota-based startup that has developed what it says is the first mitral valve implant. "[S]trategic financing from Asia and elsewhere may be what it takes to secure American leadership for many pre-revenue stage life science companies," CEO Jim Buck said.

Full Story:

Related Summaries